How much does Soto Rasib (AMG510) cost in Bangladesh?

Sotorasib is a targeted inhibitor used to treat a specific type of tumor. It is an inhibitor of the KRAS G12C mutation, a mutation common in many cancers. By inhibiting the activity of the KRAS G12C mutant protein, sotoracib blocks the signaling pathways for tumor cell proliferation and survival, thereby inhibiting the growth and spread of tumors.

Since sotoracib is not yet available in the country, domestic patients are currently unable to purchase it directly. They need to obtain the drug through foreign channels. The overseas market for sotoraxib includes both original drugs and generic drugs. Original drugs mainly come from Europe and Hong Kong, China, and are quite expensive, usually reaching tens of thousands of yuan.

However, for patients looking for a more affordable option, generic drugs on foreign markets are a viable option. In particular, the prices of Lao generic drugs, such as Lao Lucius and Lao Big Bear, have dropped significantly recently and now only cost more than one thousand to two thousand yuan, greatly reducing the financial pressure on patients. It is worth mentioning that these generic drugs have basically the same ingredients as the original drugs.

The price of Sotorasibu generic drugs in Bangladesh’s Mount Everest is around more than 4,000 yuan. Relatively speaking, Laotian generic drugs are cheaper.

The use of sotorasib is generally limited to patients with advanced tumors who are unable to receive standard chemotherapy, surgery or radiation therapy, or those who have progressed despite other treatment options. It is usually taken as an oral medication once daily. Before initiating sotorasiib, a detailed clinical evaluation of the patient is required and the presence of the KRAS G12C mutation in the tumor is required.

Sotorasiib has demonstrated good safety and tolerability in clinical trials and demonstrated significant anti-tumor activity. However, it may also cause some adverse reactions, such as respiratory tract infection, nausea, diarrhea, etc., so the patient's condition needs to be closely monitored during use and corresponding treatment measures need to be taken as needed.